Physician profile
James Manzanares
NPI 1689616989
$2,035.08
in general payments reported to CMS, 2019-2025
18 companies · $37.57 in 2025
The $37.57 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $517 · 2021: $78.05 · 2022: $15.81 · 2023: $143 · 2024: $74.65 · 2025: $37.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $757.84 | 2019 | |
| Camber Spine Technologies LLC | $382.58 | 2019-2020 | |
| Nevro Corp. | $202.82 | 2023-2024 | Senza |
| 4web, INC. | $150.00 | 2020 | |
| Zimmer Biomet Holdings, INC. | $143.46 | 2019-2021 | |
| Si-Bone, INC. | $64.59 | 2019-2021 | |
| Medtronic USA, INC. | $51.71 | 2019 | |
| Theragen, INC. | $44.93 | 2022-2025 | Actastim-S |
| Spine Wave, INC. | $43.44 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $29.53 | 2019 | |
| Boston Scientific Corporation | $24.12 | 2020 | |
| Smith+Nephew, INC. | $24.06 | 2019 | |
| Stryker Corporation | $23.76 | 2019 | |
| Carbofix Spine INC | $23.57 | 2025 | |
| Integrity Implants INC. | $23.08 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kinex Medical Company LLC | $20.21 | 2019 | |
| Spineology INC. | $13.45 | 2019 | |
| Ermi LLC | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Manzanares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.